Day One Reports First Quarter 2023 Financial Results and Corporate Progress
FIREFLY-1 clinical abstract selected for oral presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting Leadership team...
Veterans
Akari Therapeutics Reports Full-Year 2022 Financial Results and Highlights
Development of lead asset nomacopan, a novel dual-mechanism inhibitor of complement C5 and leukotriene B4 (LTB4), is focused on two...
Artella Solutions, Inc. Announces Expansion into 6 States with New Leadership Team
Growing innovative mobile cardiac telemetry company generating buzz outside of Texas to meet the diagnostic needs of providers to easily...
AUM Biosciences to Participate in Inaugural EF Hutton Global Conference
SINGAPORE and BETHESDA, Md., April 26, 2023 (GLOBE NEWSWIRE) -- AUM Biosciences Pte. Ltd. (“AUM”), a global clinical-stage biotechnology company...
electroCore Provides Select First Quarter 2023 Financial Guidance
Record revenue of approximately $2.8M expected for the three months ended March 31, 2023; 46% increase over first quarter of...
Premi Joins SoldierStrong as Chief Technology Officer
STAMFORD, Conn., April 14, 2023 (GLOBE NEWSWIRE) -- SoldierStrong, a national nonprofit committed to helping America’s military veterans take their...
TScan Therapeutics Announces Appointment of Barbara Klencke, M.D., to its Board of Directors
Barbara Klencke, M.D. Dr. Klencke is an accomplished oncology drug developer with a demonstrated track record of success, having made...
StateHouse Celebrates One-Year Anniversary
California-focused enterprise is on track to double harvest yields, achieve higher-quality biomass while reducing expenses and COGsSAN DIEGO and TORONTO,...
Clearday Inc. and Viveon Health Acquisition Corp. Announce Definitive Merger Agreement to Accelerate Innovative Longevity-Tech Platform to Market
CEO Jim Walesa will lead the combined company, Clearday, as Chief Executive Officer Jagi Gill, Chief Executive Officer and Chairman...
OXOS Medical Raises $23M Series A to Deliver “Radiology Department in a Box” to the Entire Healthcare Value Chain
Co-led by Parkway Venture Capital and Intel Capital, OXOS will leverage funds to expand into clinical, mobile, and home care...
BioCorRx Provides Business Update for 2022
Revenue Increases 343% for 2022 Due to Increased Number of Patients Treated at Licensed Clinics ANAHEIM, CA, April 03, 2023...
Achieve Life Sciences Announces Refresh to Board of Directors
SEATTLE, Wash. and VANCOUVER, British Columbia, March 30, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage...
Renalytix Reports Second Quarter and First Half Fiscal Year 2023 Financial Results
LONDON and SALT LAKE CITY, March 30, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled...
SPR Therapeutics’ 14-Month Data from Multicenter Low Back Pain Trial Demonstrates Significant, Durable Impacts on Pain Intensity, Disability, and Pain Interference
CLEVELAND, March 16, 2023 (GLOBE NEWSWIRE) -- SPR Therapeutics, a private medical device company focused on treating pain and improving...
Shiru launches OleoPro™, a protein-based alternative fat ingredient to unlock the next generation of plant-based foods
Shiru's first commercial product, OleoPro™, delivers a 90% saturated fat reduction and improved taste performance compared to current fat solutions...
Milestone Scientific Granted U.S. Government’s System for Award Management (SAM) Registration of its CompuFlo® Epidural System
SAM approval marks an important step in gaining entrée to the Department of Defense, Veterans Affairs and other government agenciesROSELAND,...
Petalfast Announces First Brand Partnership in Massachusetts, Adding Freshly Baked To Northeast Portfolio
IRVINE, Calif., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Petalfast, a route-through-market platform for the cannabis industry, announced its partnership with...
Orchestra BioMed Strengthens Senior Leadership Team
Avi Fischer, M.D., joins as SVP, Medical Affairs and Innovation; J.C. Simeon assumes role of SVP, Quality George Papandreou, Ph.D.,...
Recludix Pharma to Present at the Guggenheim Healthcare Talks Oncology Conference
SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Recludix Pharma, a leader in platform approaches to discover inhibitors of challenging...
Aerovate Therapeutics Appoints Donald Santel To Its Board of Directors
WALTHAM, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical-stage biopharmaceutical company focused on developing...